Credit Suisse Ag Aclaris Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$0.64 - $6.49 $23,374 - $237,027	36,522 Added 36.85%	135,629 $142,000
Q3 2023 Nov 13, 2023	BUY	$6.56 - $10.95 $29,277 - $48,869	4,463 Added 4.72%	99,107 $678,000
Q2 2023 Aug 11, 2023	BUY	$7.89 - $10.64 $223,697 - $301,665	28,352 Added 42.77%	94,644 $981,000
Q1 2023 May 10, 2023	BUY	$7.07 - $17.95 $9,332 - $23,694	1,320 Added 2.03%	66,292 $536,000
Q4 2022 Feb 13, 2023	BUY	$14.33 - $18.37 $337,901 - $433,164	23,580 Added 56.97%	64,972 $1.02 Million
Q3 2022 Nov 10, 2022	BUY	$13.07 - $18.22 $58,161 - $81,079	4,450 Added 12.05%	41,392 $652,000
Q2 2022 Aug 12, 2022	BUY	$10.16 - $17.08 $50,698 - $85,229	4,990 Added 15.62%	36,942 $515,000
Q1 2022 May 16, 2022	BUY	$9.74 - $17.92 $31,382 - $57,738	3,222 Added 11.21%	31,952 $550,000
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.49 $12,736 - $19,192	1,038 Added 3.75%	28,730 $418,000
Q3 2021 Nov 12, 2021	BUY	$13.38 - $18.8 $23,080 - $32,430	1,725 Added 6.64%	27,692 $499,000
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $443,516 - $768,623	25,967 New	25,967 $456,000
Q3 2019 Nov 12, 2019	SELL	$0.79 - $2.47 $40,758 - $127,434	-51,593 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.13 - $7.06 $38,665 - $128,160	18,153 Added 54.29%	51,593 $113,000
Q1 2019 May 14, 2019	BUY	$5.63 - $7.84 $754 - $1,050	134 Added 0.4%	33,440 $200,000
Q4 2018 Feb 13, 2019	BUY	$6.3 - $15.4 $62,048 - $151,674	9,849 Added 41.99%	33,306 $245,000
Q3 2018 Nov 13, 2018	SELL	$14.38 - $20.89 $240,505 - $349,385	-16,725 Reduced 41.62%	23,457 $340,000
Q2 2018 Aug 14, 2018	BUY	$16.46 - $20.33 $124,486 - $153,755	7,563 Added 23.19%	40,182 $802,000
Q1 2018 May 15, 2018	BUY	$17.08 - $25.64 $31,751 - $47,664	1,859 Added 6.04%	32,619 $571,000
Q4 2017 Feb 14, 2018	BUY	$21.47 - $27.8 $130,666 - $169,190	6,086 Added 24.67%	30,760 $759,000
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $333,260 - $416,937	14,477 Added 141.97%	24,674 $637,000
Q2 2017 Aug 14, 2017	BUY	N/A	10,197	10,197 $276,000

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

Bml Capital Management, LLC Zionsville, IN

14.3M
Shares

$54.4 Million
9.64% of portfolio
Vanguard Group Inc Valley Forge, PA

4.69M
Shares

$17.9 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

3.37M
Shares

$12.9 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.01M
Shares

$11.5 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.75M
Shares

$10.5 Million
0.11% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account